These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Nebulized prostacyclin for pulmonary hypertension: a step in the right direction. Wang A; Bashore TM Eur Heart J; 1997 Sep; 18(9):1364-5. PubMed ID: 9458437 [No Abstract] [Full Text] [Related]
47. Medical & surgical approaches to pulmonary hypertension. McLaughlin VV; Rich S Compr Ther; 1997 Sep; 23(9):612-6. PubMed ID: 9285162 [TBL] [Abstract][Full Text] [Related]
48. Use of inhaled treprostinil in patients with interstitial lung disease and pulmonary hypertension: to boldly go where no other pulmonary vasodilator has gone before? Piccari L; Wort SJ Thorax; 2024 Mar; 79(4):295-296. PubMed ID: 38307844 [No Abstract] [Full Text] [Related]
50. [Prostacyclin and iloprost in aerosol form in severe pulmonary hypertension]. Olschewski H; Walmrath D; Schermuly R; Ghofrani HA; Grimminger F; Seeger W Pneumologie; 1998 Jan; 52(1):3-7. PubMed ID: 9540363 [No Abstract] [Full Text] [Related]
51. [Vasodilators, modern therapeutic approach in pulmonary arterial hypertension]. Gherasim L; Bogdan M Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1982; 34(2):97-102. PubMed ID: 6127777 [No Abstract] [Full Text] [Related]
52. Clevidipine (Cleviprex) for IV treatment of severe hypertension. Med Lett Drugs Ther; 2008 Sep; 50(1295):73-4. PubMed ID: 18800023 [No Abstract] [Full Text] [Related]
54. Pulmonary arterial hypertension: a current review of pharmacological management. Sahni S; Ojrzanowski M; Majewski S; Talwar A Pneumonol Alergol Pol; 2016; 84(1):47-61. PubMed ID: 26693827 [TBL] [Abstract][Full Text] [Related]
55. [The combined use of sildenafil with epoprostenol in a patient with primary pulmonary hypertension]. Kayikçioğlu M; Can LH; Payzin S; Kültürsay H; Soydan I Anadolu Kardiyol Derg; 2002 Sep; 2(3):262-4. PubMed ID: 12223337 [No Abstract] [Full Text] [Related]
56. High levels of nitric oxide in individuals with pulmonary hypertension receiving epoprostenol therapy. Ozkan M; Dweik RA; Laskowski D; Arroliga AC; Erzurum SC Lung; 2001; 179(4):233-43. PubMed ID: 11891614 [TBL] [Abstract][Full Text] [Related]
57. Beraprost sodium for pulmonary hypertension with congenital heart disease. Suzuki H; Sato S; Tanabe S; Hayasaka K Pediatr Int; 2002 Oct; 44(5):528-9. PubMed ID: 12225555 [No Abstract] [Full Text] [Related]